Edition:
United Kingdom

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

55.41USD
8:16pm GMT
Change (% chg)

$-5.59 (-9.16%)
Prev Close
$61.00
Open
$61.30
Day's High
$61.30
Day's Low
$53.29
Volume
29,636
Avg. Vol
32,355
52-wk High
$76.98
52-wk Low
$34.40

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -1.09 December 14 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 5 5 5 5
(2) OUTPERFORM 2 1 1 1
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.43 1.43 1.43

Consensus Estimates Analysis

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 6 0.26 1.14 0.00 0.77
Quarter Ending Mar-19 1 0.00 0.00 0.00 0.40
Year Ending Dec-18 7 1.20 5.00 0.00 2.57
Year Ending Dec-19 6 1.78 10.00 0.00 2.17
Earnings (per share)
Quarter Ending Dec-18 6 -1.09 -0.59 -1.30 -0.68
Quarter Ending Mar-19 1 -0.97 -0.97 -0.97 --
Year Ending Dec-18 8 -3.79 -2.94 -4.29 -2.71
Year Ending Dec-19 7 -4.13 -1.35 -5.29 -3.20

Historical Surprises

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 0.09 0.02 0.07 78.97
Quarter Ending Mar-18 0.41 0.03 0.38 93.16
Quarter Ending Dec-17 0.36 0.28 0.08 21.28
Quarter Ending Sep-17 0.62 0.43 0.18 29.48
Quarter Ending Jun-17 0.78 0.44 0.34 43.19

Consensus Estimates Trend

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 0.26 0.26 0.26 0.26 0.77
Quarter Ending Mar-19 0.00 0.00 0.00 0.00 0.40
Year Ending Dec-18 1.20 1.20 1.20 1.20 2.57
Year Ending Dec-19 1.78 1.78 1.78 1.78 2.17

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 0 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings